PCG COMMITTEES

PCG DISEASE SITE COMMITTEE

Our PCG Disease Site Committee is highly experienced in the development, research, assessment, and implementation of proton therapy clinical trials for those affected by various forms of cancers.

Michael Chuong, MD
Disease Site Committee Chair
Miami Cancer Institute

J. Isabelle Choi, MD
Disease Site Committee Sub-Chair
Breast
New York Proton Center

Mark Mishra, MD
ManagerDisease Site Committee Sub-Chair Central Nervous System
Maryland Proton Center

Rupesh Kotecha, MD
Disease Site Committee Sub-Chair
Central Nervous System
Miami Cancer Institute

R. Charles Nichols, MD
Disease Site Committee Sub-Chair Gastrointestinal
University of Florida Proton Therapy Institute

Carlos Vargas, MD
Disease Site Committee Sub-Chair
Genitourinary
Mayo Clinic-Arizona

Michael Rutenberg, PhD, MD
Disease Site Committee Sub-Chair
Reirradiation
University of Florida Proton Therapy Institute

John Chang, MD
Disease Site Committee Sub-Chair
Head & Neck
Oklahoma Proton Center

Charles Simone, MD
Disease Site Committee Sub-Chair
Lung
New York Proton Center

Yolanda Tseng, MD
Disease Site Committee Sub-Chair
Lymphoma
Seattle Cancer Care Alliance Proton Therapy Center

Ronny Rotondo, MD
Disease Site Committee Sub-Chair
Pediatrics
University of Florida Proton Therapy Institute

Jonathan Ashman, MD
Disease Site Committee Sub-Chair
Mayo Clinic, Arizona

PCG PUBLICATIONS COMMITTEE

Our PCG Publications Committee is responsible for the evaluation of editorial research and material as well as the publication of various innovative studies.

J. Isabelle Choi, MD
Publications Committee Chair
New York Proton Center

John Chang, MD
Vice President/Treasurer
The California Protons Therapy Cancer Treatment Center

Lia M. Halasz, MD
Publications Committee
University of Washington, SCCA Proton Center

Brad Hoppe, MD, MPH
Publications Committee Chair
University of Florida Proton Therapy Institute

Carl Rossi, Jr, MD
Publications Committee
California Protons Cancer Therapy Center

Leslie T. Yonemoto, MD
Publications Committee

PCG Data Safety Monitoring Board

Our PCG Data Safety Monitoring Board manages the regulation and administration of clinical trial protocols and policies, to ensure patient safety.

Torunn Yock, MD
Data Safety Monitoring Board Chair
Massachusetts General Hospital

Richard Amos, PhD, Medical Physicist, MD
Anderson

Marcio Fagundes, MD
Miami Cancer Institute

Mark Pankuch, PhD, Director of Medical Physics
Northwestern Medicine Chicago Proton Center

Eugen Hug, MD
ProCure New Jersey

Randy Henderson, MD
University of Florida Proton Therapy Institute

Carlos Vargas, MD
Mayo Clinic, AZ

Charles Simone, MD
New York Proton Center

Sameer Keole, MD
Mayo Clinic, AZ

Chris Morris, MS
University of Florida Proton Therapy Institute

William Hartsell, MD Northwestern Medicine Proton Center

HsiWen Chien, PhD, Medical Physicist
Procure Oklahoma City

Stella Flampouri, PhD, Medical Physicist
University of Florida Proton Therapy Institute

Zuofeng Li, DSc, Director of Medical Physics
University of Florida Proton Therapy Institute

Andrew Chang, MD
California Protons Cancer Center

Mark Mishra, MD
University of Maryland School of Medicine

Abigail Berman, MD
Penn Center for Precision Medicine

Megan Dunn, PhD
Astellas Pharma US

WANT TO LEARN MORE?

Contact Proton Collaborative Group (PCG) today and a member of our highly trained staff will reach out to discuss any questions you may have.